- Home
- DUO vs MIRA Comparison
DUO vs MIRA Comparison
Compare DUO & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- MIRA
- Stock Information
- Founded
- DUO 2011
- MIRA 2020
- Country
- DUO China
- MIRA United States
- Employees
- DUO N/A
- MIRA N/A
- Industry
- DUO Real Estate
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- DUO Finance
- MIRA Health Care
- Exchange
- DUO Nasdaq
- MIRA Nasdaq
- Market Cap
- DUO 17.1M
- MIRA 17.4M
- IPO Year
- DUO 2019
- MIRA 2023
- Fundamental
- Price
- DUO $0.61
- MIRA $1.21
- Analyst Decision
- DUO
- MIRA Strong Buy
- Analyst Count
- DUO 0
- MIRA 2
- Target Price
- DUO N/A
- MIRA $14.00
- AVG Volume (30 Days)
- DUO 2.0M
- MIRA 474.3K
- Earning Date
- DUO 08-30-2024
- MIRA 11-12-2024
- Dividend Yield
- DUO N/A
- MIRA N/A
- EPS Growth
- DUO N/A
- MIRA N/A
- EPS
- DUO N/A
- MIRA N/A
- Revenue
- DUO $37,352,654.00
- MIRA N/A
- Revenue This Year
- DUO N/A
- MIRA N/A
- Revenue Next Year
- DUO N/A
- MIRA N/A
- P/E Ratio
- DUO N/A
- MIRA N/A
- Revenue Growth
- DUO 6.61
- MIRA N/A
- 52 Week Low
- DUO $0.32
- MIRA $0.51
- 52 Week High
- DUO $4.67
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- DUO 46.04
- MIRA 49.18
- Support Level
- DUO $0.53
- MIRA $1.13
- Resistance Level
- DUO $0.62
- MIRA $1.50
- Average True Range (ATR)
- DUO 0.05
- MIRA 0.11
- MACD
- DUO 0.00
- MIRA 0.01
- Stochastic Oscillator
- DUO 43.82
- MIRA 29.27
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. Through its subsidiaries, It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.